Atlas Trials

Neoadjuvant and Adjuvant Checkpoint Blockade

Clinical trial NCT02519322 · COMPLETED

Trial details

NCT number
NCT02519322
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cutaneous MelanomaMucosal MelanomaOcular MelanomaStage III Acral Lentiginous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIB Uveal Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7Stage IIIC Uveal Melanoma AJCC v7Stage IV Acral Lentiginous Melanoma AJCC v6 and v7Stage IV Cutaneous Melanoma AJCC v6 and v7Stage IV Uveal Melanoma AJCC v7
Start date
2016-02-02
Primary completion
2023-01-26
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.